ZYME vs TVTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ZYME

35.2
AI Score
VS
TVTX Wins

TVTX

75.2
AI Score

Investment Advisor Scores

ZYME

35score
Recommendation
AVOID NEW MONEY

TVTX

75score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZYME TVTX Winner
Forward P/E 20.8333 39.8406 ZYME
PEG Ratio 0 0 Tie
Revenue Growth -90.6% 48.2% TVTX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 35.2/100 75.2/100 TVTX
Profit Margin 0.0% -7.3% ZYME
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD TVTX

Relative Price Performance (Last 90 Days)

ZYME 1M: +3.4% · 3M: +24.4% TVTX 1M: -12.4% · 3M: -8.6%

Current Technical Phase

ZYME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.4% over 20 days), RSI 61

RSI (14): 61.0 · Price: $28.44

TVTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 38

RSI (14): 38.4 · Price: $52.43

Fundamentals Snapshot

Metric ZYME TVTX
Market Cap — —
Forward P/E 31.5 9.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% 0.5%
Gross Margin -2.5% 0.6%
Operating Margin -9.2% 0.0%
EPS -2.02 -0.74
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TVTX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.